US regulators to weigh controversial peptides backed by RFK Jr

The FDA is preparing to formally review controversial peptides marketed for sleep, muscle growth, and anti-aging, per Al Jazeera. Demand for the compounds has surged, but regulators have questioned the evidence behind the health claims.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton